Investor Overview

There are currently no events to display.

Global - Overview

Aimmune Therapeutics, Inc., is a biopharmaceutical company developing oral treatments for life-threatening food allergies. The company’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach is intended to provide meaningful levels of protection against allergic reactions resulting from exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune’s first investigational, complex biologic product, AR101, is being developed as a treatment to reduce the frequency and severity and ... more >

Recent News

more >

Upcoming Events

more >
There are currently no events to display.

Past Events

Show events starting after a certain date ( i.e. YYYY-MM-DD)
  • Webcast Image Webcast
    Aimmune Investor Symposium
    December 12, 2018
    8:00 AM EST
  • Webcast Image Webcast
    Aimmune Therapeutics Presentation at the Annual JP Morgan Healthcare Conference
    January 07, 2019
    3:00 PM PST
  • Webcast Image Webcast
    Aimmune Therapeutics Breakout Q&A session at the Annual JP Morgan Healthcare Conference
    January 07, 2019
    3:30 PM PST
  • Webcast Image Webcast
    Aimmune Therapeutics 4Q/YE 2018 Earnings Call
    February 28, 2019
    5:00 PM EST
  • Webcast Image Webcast
    Aimmune Therapeutics at the Cowen and Company 39th Annual Healthcare Conference
    March 12, 2019
    8:00 AM EDT
  • Webcast Image Webcast
    Aimmune Therapeutics at the Barclays Global Healthcare Conference
    March 13, 2019
    2:05 PM EDT
  • Webcast Image Webcast
    31st Annual ROTH Conference
    March 18, 2019
    4:30 PM EDT
  • Webcast Image Webcast
    Aimmune Data Conference Call
    March 25, 2019
    8:30 AM EDT
  • Webcast Image Webcast
    Aimmune Therapeutics at the 18th Annual Needham & Company Healthcare Conference
    April 10, 2019
    8:00 AM EDT
  • Webcast Image Webcast
    Aimmune Therapeutics 1Q/YE 2019 Earnings Call
    May 08, 2019
    4:30 PM EDT